Scroll
To Top

2020 Holiday Slider

More Info >

Barriers to Rare Disease

More Info >

RDACs

More Info >

EOY Campaign 2020

More Info >

RDD 2021

More Info >

Tools and Resources

Search NORD’s Database for reports on more than 1,200 diseases. Search database >

Find free webinars, fact sheets, infographics and other helpful materials. View resources >

Resources to help you start or grow your patient organization. View resources >

Visit our new platform where rare disease patients can fundraise, communicate and advocate.  Start now >

NORD Patient Assistance Programs help patients obtain life-saving or life-sustaining medication. View programs >

The international advocacy day to bring widespread recognition of rare diseases as a global health challenge.  Visit site >

News

  • STAT Features NORD in Article on the Continued Threat PPE Shortages Pose to Some Rare Disease Patients

    “Social distancing and mask-wearing are nothing new for people with rare diseases that raise their risk of deadly infections.”

    Read more >

  • NORD Students for Rare Member Provides Her Perspective on “Unlocking the Power of Health Care Data” Summit Panel

    “As a pre-health student, I was fascinated to hear about the ways health care is becoming digitized and how experts predict that technology will continue to become further integrated into health care in the coming years. ”

    Read more >

  • In Final Installment of Video Series, Patient Advocacy Group Leaders Share Thoughts on the Importance of Participation in RDCA-DAP

    “The RDCA-DAP initiative will allow patient organizations to leverage the data they have collected to accelerate understanding of disease progression, clinical outcome measures and biomarkers for rare diseases.”

    Read more >

  • Patient Advocacy Group Leaders Tell How Data Sharing Can Help with Understanding Rare Diseases in New Video

    “Data sharing supports patients by helping the community understand their disease better, which helps improve clinical care and can accelerate the development of new treatments.  ”

    Read more >